Yes, they refer to the current FDA classification in a document for investors advising them of the potential for negative public perception of that FDA classification. They have a fiduciary responsibility to inform investors of how something like a governmental regulator’s classification of a product might impact the success of that product and of the company as a whole.
They (Moderna) do not state that their vaccine is an “experimental gene therapy”.
So you’re wrong. Admit to it.
Currently, mRNA is considered a gene therapy product by the FDA.
I bolded it in my earlier post to you.